A growing understanding of the neurobiology of psychosis offers hope for an improvement in the standard of care; this includes the development of individualized, precision therapeutics. However, the path to precision psychiatry is long, and progress would be accelerated by greater collaboration with the fields of neurology and neuroscience.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Time to incorporate positive experiences and outcomes in psychosis research: genetic differential susceptibility to childhood experiences works for “better and for worse”
Translational Psychiatry Open Access 30 October 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

References
Hyman, S. E. Revolution stalled. Sci. Transl. Med. 4, 155cm11 (2012).
US FDA. Precision medicine. US Food and Drug Administration https://www.fda.gov/medical-devices/in-vitro-diagnostics/precision-medicine (2018).
Espay, A. J. et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 75, 1132–1141 (2018).
Clementz, B. A. et al. Psychosis biotypes: replication and validation from the B-SNIP Consortium. Schizophr. Bull. 48, 56–68 (2022).
Rosenthal, L. S. et al. The NINDS Parkinson’s disease biomarkers program. Mov. Disord. 31, 915–923 (2016).
Beauchaine, T. P., Constantino, J. N. & Hayden, E. P. Psychiatry and developmental psychopathology: unifying themes and future directions. Compr. Psychiatry 87, 143–152 (2018).
Gong, C. X., Dai, C. L., Liu, F. & Iqbal, K. Multi-targets: an unconventional drug development strategy for Alzheimer’s disease. Front. Aging Neurosci. 14, 837649 (2022).
El-Alti, L., Sandman, L. & Munthe, C. Person centered care and personalized medicine: irreconcilable opposites or potential companions? Health Care Anal. 27, 45–59 (2019).
Keshavan, M. S., Price, B. H. & Martin, J. B. The convergence of neurology and psychiatry: the importance of cross-disciplinary education. J. Am. Med. Assoc. 324, 554–555 (2020).
Samanta, D. GRIN2A-related epilepsy and speech disorders: a comprehensive overview with a focus on the role of precision therapeutics. Epilepsy Res. 189, 107065 (2023).
Acknowledgements
The authors thank J. McDowell and V. Shashi for their valuable input.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Keshavan, M.S., Clementz, B.A. Precision medicine for psychosis: a revolution at the interface of psychiatry and neurology. Nat Rev Neurol 19, 193–194 (2023). https://doi.org/10.1038/s41582-023-00788-0
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41582-023-00788-0